Technology
Health In Tech, Inc.(HIT)
Live Price
Offline$1.08
+1.89% today
1Y Change
+40.79%
Window
Jun 25, 2025 โ Jun 16, 2026
- Market Cap
- $80.00M
- Revenue Growth
- +71.0%
- EPS Growth
- +100.0%
- Dividend Yield
- 0.0%
Coverage: 245 bars ยท Jun 25, 2025 โ Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Health In Tech, Inc. (HIT) is a Technology stock with a market cap of $80.00M and listed on NASDAQ. The stock last traded around $1.08 and up 40.8% across the available one-year price window (Jun 25, 2025 โ Jun 16, 2026). Baseline metrics include revenue growth of +71.0%, EPS growth of +100.0%, a dividend yield of 0.0%. What stands out right now is revenue +71.0%, EPS +100.0%, free cash flow -104.4% with operating margin 4.6% and ROIC 6.5%. Valuation already assumes a fairly strong business story at P/E 63.3 and price/sales 2.3. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines HIT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+71.0% vs +11.9% peer median
Operating Margin
Below sector median
+4.6% vs +22.0% peer median
P/E
Above sector median
63.3 vs 18.5 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 20, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +71.0% and EPS at +100.0%, with operating margin around 4.6%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -23.7% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 20, 2026 | โ | +14.7% | +0.0% | -30.0% |
2026 Mar 25, 2026 | +75.0% | -11.0% | -21.5% | -16.6% |
2025 Nov 10, 2025 | +0.0% | -26.4% | -49.7% | -63.0% |
Benchmark Edge
HIT vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
HIT
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
HIT Max Drawdown
-77.03%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for HIT and SPY.
Company Overview
Health In Tech, Inc.
NASDAQ Capital Market
Health In Tech, Inc. operates as an insurance technology platform company. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small to medium sized employers. It also provides health intelligence (HI) card to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.
- Leadership
- Tim Johnson
- IPO Date
- Dec 23, 2024
- Employees
- 73
- Street Address
- 701 S. Colorado Ave
- Mailing
- Stuart, FL, 34994
- Region
- Stuart, FL, US
- Reporting Currency
- USD
- Investor Line
- 888 373 0333
- Last Updated
- Apr 29, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 63.3
- EV/EBITDA
- 27.4
- Price/Sales
- 2.3
- Price/Book
- 4.7
Growth
- Revenue
- +71.0%
- EPS
- +100.0%
- Free Cash Flow
- -104.4%
Profitability
- Gross Margin
- 62.8%
- Operating Margin
- 4.6%
- Net Margin
- 3.8%
- ROE
- 7.9%
- ROIC
- 6.5%
Balance Sheet
- Debt/Equity
- 0.01
- Current Ratio
- 3.13
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.